CorriXR Therapeutics is a biotechnology company.
CorriXR Therapeutics has raised $1.0M in total funding. The most recent round was Series A. The last funding was announced in August 2025.
CorriXR Therapeutics's investors include Cortado Ventures, Southern Research, Christiana Care Health Systems, State of Delaware, Brookhaven Bio.
CorriXR Therapeutics is headquartered in Wilmington, United States.
CorriXR Therapeutics is a biotechnology company.
CorriXR Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CorriXR Therapeutics — Funding & Investors." VCBacked, August 19, 2025, https://www.vcbacked.co/company/corrixr-therapeutics. Accessed October 23, 2026.
VCBacked. (2025). CorriXR Therapeutics — Funding & Investors. Retrieved October 23, 2026, from https://www.vcbacked.co/company/corrixr-therapeutics
{{cite web |title=CorriXR Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/corrixr-therapeutics |website=VCBacked |access-date=October 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated